TEIJINHuman Chemistry, Human Solutions

Teijin Pharma Limited GLOBAL

  • Site Map
  • Contact Us
  • Enlarge Text

menu

  • About Us
  • Our Business Structure
  • Site Map
  • Contact Us

About Us：TOP

  • Corporate Philosophy
  • Message from the President
  • Group Synergies
  • Office Locations
  • Alliance Partners
  • History
  • Corporate Social Responsibility
  • Project Stories
  • News

Our Business Structure：TOP

Business Fields
  • About Teijin Pharma
Business Activities
  • Research & Development
  • Industrial Technology
  • Regulatory Compliance

  • Japan Local Site日本

Home > News Release > 2023

News Release

2023

Nov. 29, 2023
  • Notice Concerning a Decision on the Licensing Agreement related to the Three Hormone Therapy Drugs for Rare Endocrine Diseases
Jul. 03, 2023
  • Teijin and Axcelead to Establish Drug Discovery Research Joint Venture
Mar. 06, 2023
  • Teijin Pharma Grants Global Exclusive Licens for Investigational Small Molecule Candidate in Kidney Disease

Page Top

News Release

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • Notice

We use cookies to help improve your experience on our website. Clink on "Agree" to agree and proceed, or click on "See Details" for more information and settings of cookies.

See Details
  • Terms & Conditions of Use
  • Privacy Policy

Copyright © Teijin Pharma Limited. All Rights Reserved.